{"id":3170,"date":"2026-11-17T14:32:56","date_gmt":"2026-11-17T19:32:56","guid":{"rendered":"https:\/\/haidut.me\/?p=3170"},"modified":"2026-11-17T14:32:56","modified_gmt":"2026-11-17T19:32:56","slug":"inflammatory-mediators-derived-from-pufa-including-omega-3-may-drive-long-covid","status":"publish","type":"post","link":"https:\/\/haidut.me\/?p=3170","title":{"rendered":"Inflammatory mediators derived from PUFA (including omega-3) may drive long COVID"},"content":{"rendered":"<p>Since the pandemic, medicine has added a new condition to its dictionary. Namely, the so-called &#8220;long COVID&#8221;, which seems to encompass virtually all symptoms previously ascribed to the so-called chronic fatigue syndrome (CFS). After almost 2 decades denying that CFS exists, I believe medicine has now finally recognized the condition as &#8220;organic&#8221;, but treatment options are still limited. Well, if long COVID turns out to be more or less the same as CFS, the study below may offer a clue to its cause(s) and a possible treatment for both conditions. While chronic inflammation has been suspected since late 2020 to be a core factor in long COVID, the specific mediators have not been conclusively identified yet. The study below identifies at least some of the specific inflammation mediators and, unsurprisingly, they are all derived from PUFA. While the omega-6 members of the PUFA family are well-known mediators of inflammation, perhaps the most surprising finding of the study is that even mediators derives from the &#8220;beneficial&#8221; omega-3 lipids EPA and DHA (commonly found in fatty fish) can also be highly inflammatory and contribute to the long-term inflammatory load shown to be present in long COVID. The main PUFA-fed inflammatory pathways are COX and LOX. Interestingly, the study found that only the LOX pathway mediators are elevated in long COVID, which would seem to suggest that aspirin may have a relatively limited benefit (at least for inflammation) in this condition, since aspirin is predominantly a COX inhibitor. However, aspirin has other anti-inflammatory benefits due to its pro-metabolic effects, which may explain why aspirin has been found in some studies to benefit patients with long COVID. Other known LOX inhibitors include vitamin E, emodin, pregnane (progesterone\/pregnenolone) steroids, androgens, etc., and they have all shown benefit in pre-clinical models of long COVID.<\/p>\n<p><a href=\"https:\/\/doi.org\/10.1016\/j.isci.2026.117581\">https:\/\/doi.org\/10.1016\/j.isci.2026.117581<\/a><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"C7h9h017WH\"><p><a href=\"https:\/\/bioengineer.org\/long-covid-linked-to-overactive-fat-metabolizing-enzymes-that-fail-to-resolve-inflammation\/\">Long COVID Linked to Overactive Fat-Metabolizing Enzymes That Fail to Resolve Inflammation<\/a><\/p><\/blockquote>\n<p><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;Long COVID Linked to Overactive Fat-Metabolizing Enzymes That Fail to Resolve Inflammation&#8221; &#8212; BIOENGINEER.ORG\" src=\"https:\/\/bioengineer.org\/long-covid-linked-to-overactive-fat-metabolizing-enzymes-that-fail-to-resolve-inflammation\/embed\/#?secret=VVXwc91dNw#?secret=C7h9h017WH\" data-secret=\"C7h9h017WH\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<p>&#8220;&#8230;<span style=\"text-decoration: underline;\"><strong>Long COVID affects an estimated 5 to 10 percent of adults after infection with SARS-CoV-2, leaving many with fatigue, brain fog, shortness of breath, and loss of smell or taste<\/strong><\/span> that can persist for years. <span style=\"text-decoration: underline;\"><strong>Despite a growing catalog of clinical risk factors<\/strong><\/span>, including female sex, lack of vaccination, pre-existing comorbidities, and greater severity of the initial illness, <span style=\"text-decoration: underline;\"><strong>the biology underlying the condition has remained stubbornly elusive<\/strong><\/span>. Now, a study published in the journal iScience points to a surprising culprit: <span style=\"text-decoration: underline;\"><strong>the way the body metabolizes dietary <span style=\"color: #ff0000; text-decoration: underline;\">essential fatty acids<\/span> during and after infection, and specifically the activity of a family of enzymes called <span style=\"color: #ff0000; text-decoration: underline;\">lipoxygenases<\/span><\/strong><\/span> that normally help shut inflammation down.&#8221;<\/p>\n<p>&#8220;&#8230;The logic behind the approach rests on a well-established but underappreciated branch of immunology. <span style=\"text-decoration: underline;\"><strong>Essential <span style=\"color: #ff0000; text-decoration: underline;\">polyunsaturated fatty acids such as arachidonic acid, docosahexaenoic acid, and eicosapentaenoic acid<\/span> are not merely fuel; they are raw materials<\/strong><\/span> for an entire pharmacopeia of signaling molecules. <span style=\"text-decoration: underline;\"><strong>Lipoxygenase enzymes convert these fats into specialized pro-resolving mediators<\/strong><\/span>, including lipoxins, resolvins, protectins, and maresins, which actively coordinate the return of tissues to homeostasis after injury or infection. <span style=\"text-decoration: underline;\"><strong>In a self-limited inflammatory response, the body performs a metabolic class switch, pivoting from pro-inflammatory prostaglandins and leukotrienes to these pro-resolving mediators. <span style=\"color: #ff0000; text-decoration: underline;\">If that switch fails, inflammation can smolder indefinitely<\/span><\/strong><\/span>.&#8221;<\/p>\n<p>&#8220;&#8230;The first major finding came from the acute phase. In samples drawn within 30 days of a positive test, participants who would later develop <span style=\"text-decoration: underline; color: #ff0000;\"><strong>Long COVID showed significantly elevated levels of three products of the 12-lipoxygenase enzyme: 12-hydroxyeicosatetraenoic acid from arachidonic acid, 14-hydroxydocosahexaenoic acid from DHA, and 12-hydroxyeicosapentaenoic acid from EPA<\/strong><\/span>. This association held even after the researchers statistically controlled for the severity of the initial infection, gender, and self-reported race. A composite score <span style=\"text-decoration: underline;\"><strong>aggregating all 12-lipoxygenase products was likewise a significant predictor of later Long COVID, as were aggregate measures of arachidonic acid and EPA metabolism<\/strong><\/span>. Notably, the pattern was not simply a byproduct of generalized platelet activation, since thromboxane products of platelet cyclooxygenase were not elevated.&#8221;<\/p>\n<p>&#8220;&#8230;After the first month, the picture shifted. In cross-sectional samples collected more than a month post-infection, the correlation structure of the lipidome itself had changed. In recovered participants, intermediates derived from the same parent fatty acid tended to rise and fall together, indicating that metabolism was organized around the available fats. In Long COVID participants, this within-family correlation was lost for the DHA and EPA families, while <span style=\"text-decoration: underline;\"><strong>a strong signature of 5-lipoxygenase activation emerged across fatty acid families<\/strong><\/span>. The authors interpret this as <span style=\"text-decoration: underline;\"><strong>an uncoupling of PUFA metabolism in Long COVID<\/strong><\/span>, in which enzyme activity, rather than substrate availability, drives the lipid profile, consistent with disrupted lipid mediator class switching.&#8221;<\/p>\n<p>Longitudinal sampling over the first year after infection sharpened the temporal picture. <span style=\"text-decoration: underline;\"><strong>Levels of 15-HETE, an arachidonic acid product, remained significantly higher in Long COVID participants<\/strong><\/span>, while resolvin D1 was consistently lower; indeed, resolvin D1 was undetectable in 14.3 percent of Long COVID samples but in none of the recovered samples. Several metabolites, including 17-HDoHE, 14-HDoHE, and lipoxin A4, showed significant interactions with time, diverging between the groups in the three-to-nine-month window after infection. These trajectories suggest that <span style=\"text-decoration: underline;\"><strong><span style=\"color: #ff0000; text-decoration: underline;\">lipoxygenase activity remains elevated for months in Long COVID<\/span> even as production of key pro-resolving mediators stays depressed<\/strong><\/span>, a combination that could sustain <span style=\"text-decoration: underline;\"><strong>defective resolution of inflammation<\/strong><\/span>.&#8221;<\/p>\n<p>&#8220;&#8230;The study also intersected with another leading hypothesis about Long COVID: persistence of viral proteins. Using ultra-sensitive single molecule array assays, the researchers detected SARS-CoV-2 spike protein in a subset of both Long COVID and recovered participants long after acute infection, and unsupervised clustering of the multidimensional data separated samples largely by the presence or absence of spike. <span style=\"text-decoration: underline; color: #ff0000;\"><strong>Within Long COVID samples, plasma levels of 17-HDoHE correlated significantly with spike protein abundance, a relationship absent in recovered participants<\/strong><\/span>. When the team clustered Long COVID samples using lipid mediators alone, four distinct biochemical subtypes emerged, one enriched in 17-HDoHE and another almost entirely lacking resolvin D1, hinting that <span style=\"text-decoration: underline;\"><strong>Long COVID may encompass several metabolically distinct endotypes rather than a single disease process<\/strong><\/span>.&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Since the pandemic, medicine has added a new condition to its dictionary. Namely, the so-called &#8220;long COVID&#8221;,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[2279,2264,420,12,394,393,1043,1042,159],"class_list":["post-3170","post","type-post","status-publish","format-standard","hentry","category-science","tag-covid","tag-dha","tag-epa","tag-inflammation","tag-lipoxygenase","tag-lox","tag-omega-3","tag-omega-6","tag-pufa","wpcat-2-id"],"_links":{"self":[{"href":"https:\/\/haidut.me\/index.php?rest_route=\/wp\/v2\/posts\/3170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haidut.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haidut.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haidut.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haidut.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3170"}],"version-history":[{"count":1,"href":"https:\/\/haidut.me\/index.php?rest_route=\/wp\/v2\/posts\/3170\/revisions"}],"predecessor-version":[{"id":3171,"href":"https:\/\/haidut.me\/index.php?rest_route=\/wp\/v2\/posts\/3170\/revisions\/3171"}],"wp:attachment":[{"href":"https:\/\/haidut.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haidut.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haidut.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}